National Genetics Institute; a LabCorp subsidiary

National Genetics Institute, a LabCorp subsidiary, stands at the forefront of biotechnology, delivering advanced genetics testing services across various critical domains, including blood screening, medical diagnostics, and clinical research. With a commitment to innovation, National Genetics Institute offers a comprehensive suite of industry-leading assays designed to detect human immunodeficiency virus (HIV), hepatitis A, B, and C (HAV, HBV, and HCV) viruses, as well as other infectious agents. The company has pioneered robust, sensitive, and high-throughput methods for pooled specimen nucleic acid testing, ensuring accuracy and efficiency.

National Genetics Institute operates as a licensed clinical laboratory provider, adhering to stringent state and federal regulations. Participation in numerous approved quality control programs underscores the company's dedication to maintaining the highest standards of excellence. Furthermore, National Genetics Institute holds active Biologics Licenses from the US Food and Drug Administration (FDA) for screening plasma for blood-borne infectious agents, reinforcing its position as a trusted leader in the field.

National Genetics Institute, a key LabCorp subsidiary, is dedicated to advancing genetic testing technologies and improving healthcare outcomes. We invite the manager of National Genetics Institute to create a customized and exclusive company showcase and product listing on our platform to further highlight its capabilities and reach a wider audience.